Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

Clinical trial NCT01192243 · UNKNOWN

Trial details

NCT number: NCT01192243
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Toxicity Non-small Cell Lung Cancer

Start date: 2009-12-01
Primary completion: 2011-12-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.